Labcyte Awarded 1st Patent in China
“The life sciences industry in China is the world’s highest growth market and the pharmaceutical and biotech markets are expected to be the 3rd largest market, after the USA and EU, in the world by 2013 at $73 billion,” said Sanger Chang, General Manager of Tekon Biotech, the Labcyte distributor in China. “Labcyte products have already been successfully adopted by some of the largest pharmaceutical and CRO companies in China as well as by all ten of the top ten pharmaceutical companies globally. As discovery platforms are standardized and adopted globally we see significant opportunity for the Labcyte products in China.”
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.